The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Carbohydrate Antigen 19-9 Market Research Report 2024
Synopsis
Carbohydrate antigen 19-9 is a tetrasaccharide which is usually attached to O-glycans on the surface of cells. It is known to play a vital role in cell-to-cell recognition processes. It is also a tumor marker used primarily in the management of pancreatic cancer.
The global Carbohydrate Antigen 19-9 market was valued at US$ 94 million in 2023 and is anticipated to reach US$ 145.9 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
Global Carbohydrate Antigen 19-9 main manufactuers include Abbott, Ropv and Ortho Clinical Diagnostics. In terms of the type of Carbohydrate Antigen 19-9, it can be divided into ELISA and CLIA. CLIA is the largest market, with a share over 70%.
This report aims to provide a comprehensive presentation of the global market for Carbohydrate Antigen 19-9, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbohydrate Antigen 19-9.
Report Scope
The Carbohydrate Antigen 19-9 market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carbohydrate Antigen 19-9 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carbohydrate Antigen 19-9 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Roche
Ortho Clinical Diagnostics
BioMérieux
Fujirebio
KAINOS Laboratories
DiaSorin
Danaher Corporation
Siemens
Tellgen
DIACHA Diagnostics
Sichuan Maccura Biotechnology
Dirui
Chemclin IVD
Segment by Type
ELISA
CLIA
Segment by Application
Pancreatic Cancer
Colon Cancer
Stomach Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Carbohydrate Antigen 19-9 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Carbohydrate Antigen 19-9 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Carbohydrate antigen 19-9 is a tetrasaccharide which is usually attached to O-glycans on the surface of cells. It is known to play a vital role in cell-to-cell recognition processes. It is also a tumor marker used primarily in the management of pancreatic cancer.
The global Carbohydrate Antigen 19-9 market was valued at US$ 94 million in 2023 and is anticipated to reach US$ 145.9 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
Global Carbohydrate Antigen 19-9 main manufactuers include Abbott, Ropv and Ortho Clinical Diagnostics. In terms of the type of Carbohydrate Antigen 19-9, it can be divided into ELISA and CLIA. CLIA is the largest market, with a share over 70%.
This report aims to provide a comprehensive presentation of the global market for Carbohydrate Antigen 19-9, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbohydrate Antigen 19-9.
Report Scope
The Carbohydrate Antigen 19-9 market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carbohydrate Antigen 19-9 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carbohydrate Antigen 19-9 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Roche
Ortho Clinical Diagnostics
BioMérieux
Fujirebio
KAINOS Laboratories
DiaSorin
Danaher Corporation
Siemens
Tellgen
DIACHA Diagnostics
Sichuan Maccura Biotechnology
Dirui
Chemclin IVD
Segment by Type
ELISA
CLIA
Segment by Application
Pancreatic Cancer
Colon Cancer
Stomach Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Carbohydrate Antigen 19-9 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Carbohydrate Antigen 19-9 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Carbohydrate Antigen 19-9 Market Overview
1.1 Product Overview and Scope of Carbohydrate Antigen 19-9
1.2 Carbohydrate Antigen 19-9 Segment by Type
1.2.1 Global Carbohydrate Antigen 19-9 Market Value Comparison by Type (2024-2030)
1.2.2 ELISA
1.2.3 CLIA
1.3 Carbohydrate Antigen 19-9 Segment by Application
1.3.1 Global Carbohydrate Antigen 19-9 Market Value by Application: (2024-2030)
1.3.2 Pancreatic Cancer
1.3.3 Colon Cancer
1.3.4 Stomach Cancer
1.3.5 Others
1.4 Global Carbohydrate Antigen 19-9 Market Size Estimates and Forecasts
1.4.1 Global Carbohydrate Antigen 19-9 Revenue 2019-2030
1.4.2 Global Carbohydrate Antigen 19-9 Sales 2019-2030
1.4.3 Global Carbohydrate Antigen 19-9 Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Carbohydrate Antigen 19-9 Market Competition by Manufacturers
2.1 Global Carbohydrate Antigen 19-9 Sales Market Share by Manufacturers (2019-2024)
2.2 Global Carbohydrate Antigen 19-9 Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Carbohydrate Antigen 19-9 Average Price by Manufacturers (2019-2024)
2.4 Global Carbohydrate Antigen 19-9 Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Carbohydrate Antigen 19-9, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Carbohydrate Antigen 19-9, Product Type & Application
2.7 Carbohydrate Antigen 19-9 Market Competitive Situation and Trends
2.7.1 Carbohydrate Antigen 19-9 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Carbohydrate Antigen 19-9 Players Market Share by Revenue
2.7.3 Global Carbohydrate Antigen 19-9 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Carbohydrate Antigen 19-9 Retrospective Market Scenario by Region
3.1 Global Carbohydrate Antigen 19-9 Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Carbohydrate Antigen 19-9 Global Carbohydrate Antigen 19-9 Sales by Region: 2019-2030
3.2.1 Global Carbohydrate Antigen 19-9 Sales by Region: 2019-2024
3.2.2 Global Carbohydrate Antigen 19-9 Sales by Region: 2025-2030
3.3 Global Carbohydrate Antigen 19-9 Global Carbohydrate Antigen 19-9 Revenue by Region: 2019-2030
3.3.1 Global Carbohydrate Antigen 19-9 Revenue by Region: 2019-2024
3.3.2 Global Carbohydrate Antigen 19-9 Revenue by Region: 2025-2030
3.4 North America Carbohydrate Antigen 19-9 Market Facts & Figures by Country
3.4.1 North America Carbohydrate Antigen 19-9 Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Carbohydrate Antigen 19-9 Sales by Country (2019-2030)
3.4.3 North America Carbohydrate Antigen 19-9 Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Carbohydrate Antigen 19-9 Market Facts & Figures by Country
3.5.1 Europe Carbohydrate Antigen 19-9 Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Carbohydrate Antigen 19-9 Sales by Country (2019-2030)
3.5.3 Europe Carbohydrate Antigen 19-9 Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Carbohydrate Antigen 19-9 Market Facts & Figures by Country
3.6.1 Asia Pacific Carbohydrate Antigen 19-9 Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Carbohydrate Antigen 19-9 Sales by Country (2019-2030)
3.6.3 Asia Pacific Carbohydrate Antigen 19-9 Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Carbohydrate Antigen 19-9 Market Facts & Figures by Country
3.7.1 Latin America Carbohydrate Antigen 19-9 Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Carbohydrate Antigen 19-9 Sales by Country (2019-2030)
3.7.3 Latin America Carbohydrate Antigen 19-9 Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Carbohydrate Antigen 19-9 Market Facts & Figures by Country
3.8.1 Middle East and Africa Carbohydrate Antigen 19-9 Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Carbohydrate Antigen 19-9 Sales by Country (2019-2030)
3.8.3 Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Carbohydrate Antigen 19-9 Sales by Type (2019-2030)
4.1.1 Global Carbohydrate Antigen 19-9 Sales by Type (2019-2024)
4.1.2 Global Carbohydrate Antigen 19-9 Sales by Type (2025-2030)
4.1.3 Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2019-2030)
4.2 Global Carbohydrate Antigen 19-9 Revenue by Type (2019-2030)
4.2.1 Global Carbohydrate Antigen 19-9 Revenue by Type (2019-2024)
4.2.2 Global Carbohydrate Antigen 19-9 Revenue by Type (2025-2030)
4.2.3 Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2019-2030)
4.3 Global Carbohydrate Antigen 19-9 Price by Type (2019-2030)
5 Segment by Application
5.1 Global Carbohydrate Antigen 19-9 Sales by Application (2019-2030)
5.1.1 Global Carbohydrate Antigen 19-9 Sales by Application (2019-2024)
5.1.2 Global Carbohydrate Antigen 19-9 Sales by Application (2025-2030)
5.1.3 Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2019-2030)
5.2 Global Carbohydrate Antigen 19-9 Revenue by Application (2019-2030)
5.2.1 Global Carbohydrate Antigen 19-9 Revenue by Application (2019-2024)
5.2.2 Global Carbohydrate Antigen 19-9 Revenue by Application (2025-2030)
5.2.3 Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2019-2030)
5.3 Global Carbohydrate Antigen 19-9 Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Carbohydrate Antigen 19-9 Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche Carbohydrate Antigen 19-9 Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Ortho Clinical Diagnostics
6.3.1 Ortho Clinical Diagnostics Corporation Information
6.3.2 Ortho Clinical Diagnostics Description and Business Overview
6.3.3 Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Product Portfolio
6.3.5 Ortho Clinical Diagnostics Recent Developments/Updates
6.4 BioMérieux
6.4.1 BioMérieux Corporation Information
6.4.2 BioMérieux Description and Business Overview
6.4.3 BioMérieux Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BioMérieux Carbohydrate Antigen 19-9 Product Portfolio
6.4.5 BioMérieux Recent Developments/Updates
6.5 Fujirebio
6.5.1 Fujirebio Corporation Information
6.5.2 Fujirebio Description and Business Overview
6.5.3 Fujirebio Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Fujirebio Carbohydrate Antigen 19-9 Product Portfolio
6.5.5 Fujirebio Recent Developments/Updates
6.6 KAINOS Laboratories
6.6.1 KAINOS Laboratories Corporation Information
6.6.2 KAINOS Laboratories Description and Business Overview
6.6.3 KAINOS Laboratories Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2019-2024)
6.6.4 KAINOS Laboratories Carbohydrate Antigen 19-9 Product Portfolio
6.6.5 KAINOS Laboratories Recent Developments/Updates
6.7 DiaSorin
6.6.1 DiaSorin Corporation Information
6.6.2 DiaSorin Description and Business Overview
6.6.3 DiaSorin Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 DiaSorin Carbohydrate Antigen 19-9 Product Portfolio
6.7.5 DiaSorin Recent Developments/Updates
6.8 Danaher Corporation
6.8.1 Danaher Corporation Corporation Information
6.8.2 Danaher Corporation Description and Business Overview
6.8.3 Danaher Corporation Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Danaher Corporation Carbohydrate Antigen 19-9 Product Portfolio
6.8.5 Danaher Corporation Recent Developments/Updates
6.9 Siemens
6.9.1 Siemens Corporation Information
6.9.2 Siemens Description and Business Overview
6.9.3 Siemens Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Siemens Carbohydrate Antigen 19-9 Product Portfolio
6.9.5 Siemens Recent Developments/Updates
6.10 Tellgen
6.10.1 Tellgen Corporation Information
6.10.2 Tellgen Description and Business Overview
6.10.3 Tellgen Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tellgen Carbohydrate Antigen 19-9 Product Portfolio
6.10.5 Tellgen Recent Developments/Updates
6.11 DIACHA Diagnostics
6.11.1 DIACHA Diagnostics Corporation Information
6.11.2 DIACHA Diagnostics Carbohydrate Antigen 19-9 Description and Business Overview
6.11.3 DIACHA Diagnostics Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2019-2024)
6.11.4 DIACHA Diagnostics Carbohydrate Antigen 19-9 Product Portfolio
6.11.5 DIACHA Diagnostics Recent Developments/Updates
6.12 Sichuan Maccura Biotechnology
6.12.1 Sichuan Maccura Biotechnology Corporation Information
6.12.2 Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Description and Business Overview
6.12.3 Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Product Portfolio
6.12.5 Sichuan Maccura Biotechnology Recent Developments/Updates
6.13 Dirui
6.13.1 Dirui Corporation Information
6.13.2 Dirui Carbohydrate Antigen 19-9 Description and Business Overview
6.13.3 Dirui Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Dirui Carbohydrate Antigen 19-9 Product Portfolio
6.13.5 Dirui Recent Developments/Updates
6.14 Chemclin IVD
6.14.1 Chemclin IVD Corporation Information
6.14.2 Chemclin IVD Carbohydrate Antigen 19-9 Description and Business Overview
6.14.3 Chemclin IVD Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Chemclin IVD Carbohydrate Antigen 19-9 Product Portfolio
6.14.5 Chemclin IVD Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Carbohydrate Antigen 19-9 Industry Chain Analysis
7.2 Carbohydrate Antigen 19-9 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Carbohydrate Antigen 19-9 Production Mode & Process
7.4 Carbohydrate Antigen 19-9 Sales and Marketing
7.4.1 Carbohydrate Antigen 19-9 Sales Channels
7.4.2 Carbohydrate Antigen 19-9 Distributors
7.5 Carbohydrate Antigen 19-9 Customers
8 Carbohydrate Antigen 19-9 Market Dynamics
8.1 Carbohydrate Antigen 19-9 Industry Trends
8.2 Carbohydrate Antigen 19-9 Market Drivers
8.3 Carbohydrate Antigen 19-9 Market Challenges
8.4 Carbohydrate Antigen 19-9 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
